Non-occluding Pump Shutdown Sequence for Extracorporeal Blood Treatment

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Non-occluding pumps in extracorporeal blood treatment apparatuses pose a risk of uncontrolled fluid flow, particularly blood flow in reverse direction, when shut off or reduced in speed, due to the absence of occlusion bodies.

Innovation Solution

Implementing a time-delayed shut-off or reduction in pump speed, accompanied by controlled shut-off elements and pressure management using ventilation valves or ultrafiltration devices, to prevent reverse flow by creating excess pressure in the fluid system before opening shut-off elements.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Productivity

If non-occluding pump is shut off or reduced in speed, then productivity is improved (treatment can be paused or adjusted), but reliability deteriorates (risk of uncontrolled reverse flow)

Engineering Contradiction:
Improvepump speed controlVSAvoidfluid directionality
Core Design Contradiction:
ProductivityVSReliability

Solution Approach 1:

The patent applies preliminary action by closing shut-off elements before shutting off or reducing pump speed. This sequence ensures that the fluid pathway is sealed in advance, preventing any potential reverse flow that could occur when the pump stops or slows down. The control unit coordinates this preliminary closure action to maintain reliability while allowing productivity adjustments.

Inventive Principle:
Principle #10Preliminary action

2Ease of operation

If non-occluding pump is used, then ease of operation is improved (no occlusion bodies to manage), but reliability deteriorates (no inherent reverse flow prevention)

Engineering Contradiction:
Improvepump structure simplicityVSAvoidreverse flow prevention
Core Design Contradiction:
Ease of operationVSReliability

Solution Approach 1:

The patent introduces shut-off elements as intermediary components that provide reverse flow prevention without requiring modification to the pump structure itself. These elements act as mediators between the simple non-occluding pump and the reliability requirement, enabling the pump to maintain its operational simplicity while ensuring controlled fluid directionality through the coordinated action of shut-off elements and timing control.

Inventive Principle:
Principle #24Intermediary (Mediator)

3Loss of time

If pump is shut off immediately, then time is saved (no delay), but harmful factors increase (excess pressure buildup causing uncontrolled flow)

Engineering Contradiction:
Improveshut-off delayVSAvoidexcess pressure
Core Design Contradiction:
Loss of timeVSObject-generated harmful factors

Solution Approach 1:

The patent applies preliminary action by closing shut-off elements before pump shutdown, which allows the system to manage pressure buildup proactively. This preliminary closure enables controlled pressure equalization through alternative pathways (such as ventilation valves or ultrafiltration) before the pump stops, preventing harmful excess pressure from developing while accepting a minimal, controlled time delay.

Inventive Principle:
Principle #10Preliminary action

Solution Approach 2:

The patent converts the potentially harmful excess pressure into a beneficial control mechanism by using it to drive fluid through alternative pathways (ventilation, ultrafiltration) that safely relieve pressure. The controlled pressure buildup becomes a driving force for pressure equalization rather than a harmful effect, eliminating uncontrolled reverse flow while maintaining system safety.

Inventive Principle:
Principle #22Blessing in disguise (Convert harm into benefit)

Data Source

PatentUS10335529B2Extra-corporeal blood treatment device and method for switching off or reducing the speed of a non-occluding pump in a fluid system of an extra-corporeal blood device
Publication Date: 2019.07.02 FRESENIUS MEDICAL CARE DEUTSCHLAND GMBH
  • US10335529B2 patent drawing
  • US10335529B2 patent drawing
  • US10335529B2 patent drawing

AI summary

An extracorporeal blood treatment apparatus having a fluid system and a pump for conveying fluid in the fluid system, wherein the pump is a non-occluding pump, and a method for shutting off or reducing the speed of rotation of a non-occluding pump in a fluid system of an extracorporeal blood treatment apparatus. The apparatus and the method are characterized in that before the speed of rotation is reduced or the pump is shut off, the fluid flow into the feed line and out of the discharge line is first interrupted, and after a predetermined time interval after interruption of the fluid flow has elapsed, the speed of rotation of the pump is reduced or the pump is shut off. The time-delayed shut-off of the pump prevents a reverse flow of fluid, particularly of blood into the arterial blood line, even in the absence of occlusion. As a result of the time-delayed shut-off or reduction in the speed of rotation of the pump, however, an excess pressure is produced in the fluid system. Therefore the blood treatment apparatus and the method provide for counter-measures to prevent uncontrolled fluid flow when the shut-off elements are opened, due to the excess pressure.